Metabolites · 2022 · 21 citations · 47 references
Life SciencesImmunologyPharmacologyAutoimmunityInflammationRheumatologyAutoimmune Rheumatic DiseasesInflammatory ArthritisNeutrophil BiologyOxidative Stress In InflammationRheumatoid ArthritisJak Inhibitor TherapyJak InhibitorsJanus Kinase Inhibitor TherapyJanus Kinase-stat Signaling ActivationNeutrophil Function ModulationNeutrophil InvolvementNeutrophil MetabolismRheumatoid Arthritis Therapy
Neutrophils play a key role in the pathophysiology of rheumatoid arthritis (RA) where release of ROS and proteases directly causes damage to joints and tissues. Neutrophil function can be modulated by Janus Kinase (JAK) inhibitor drugs, including tofacitinib and baricitinib, which are clinically effective treatments for RA. However, clinical trials have reported increased infection rates and transient neutropenia during therapy. The subtle differences in the mode of action, efficacy and safety of JAK inhibitors have been the primary research topic of many clinical trials and systematic reviews, to provide a more precise and targeted treatment to patients. The aim of this study was to determine both the differences in the metabolome of neutrophils from healthy controls and people with RA, and the effect of different JAK inhibitors on the metabolome of healthy and RA neutrophils. Isolated neutrophils from healthy controls (HC) (n = 6) and people with RA (n = 7) were incubated with baricitinib, tofacitinib or a pan-JAK inhibitor (all 200 ng/mL) for 2 h. Metabolites were extracted, and 1H nuclear magnetic resonance (NMR) was applied to study the metabolic changes. Multivariate analyses and machine learning models showed a divergent metabolic pattern in RA neutrophils compared to HC at 0 h (F1 score = 86.7%) driven by energy metabolites (ATP, ADP, GTP and glucose). No difference was observed in the neutrophil metabolome when treated with JAK inhibitors. However, JAK inhibitors significantly inhibited ROS production and baricitinib decreased NET production (p < 0.05). Bacterial killing was not impaired by JAK inhibitors, indicating that the effect of JAK inhibitors on neutrophils can inhibit joint damage in RA without impairing host defence. This study highlights altered energy metabolism in RA neutrophils which may explain the cause of their dysregulation in inflammatory disease.
47
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin, Ignacio Arganda‐Carreras, Erwin Frise et al. · Nature Methods · 2012 · 70.9K citations
Daniel Aletaha, Tuhina Neogi, Alan J. Silman et al. · Arthritis & Rheumatism · 2010 · 9.6K citations · Full text
Medicine, Internal Medicine, Clinical Classification Systems +13
Proposed minimum reporting standards for chemical analysis
Lloyd W. Sumner, Alexander Amberg, Michael H. Beale et al. · Metabolomics · 2007 · 5K citations · Full text
mixOmics: An R package for ‘omics feature selection and multiple data integration
Florian Rohart, Benoît Gautier, Amrit Singh et al. · PLoS Computational Biology · 2017 · 3.9K citations · Full text